$GBUX

RUB A DUB SOAP INC

CIK:0001169138|SEC Filings

Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Consolidated Statement of Operations (Unaudited)
Revenue	$ 34,264	$ 55,803	$ 90,170	$ 121,826
Cost of revenue	27,413	39,434	57,339	94,584
Gross profit	6,851	16,369	32,831	27,242
Operating expenses
General and administrative	110,412	303,115	371,603	482,641
Sales and marketing	5,949	68,492	6,049	68,577
Stock based-compensation -commitment fees	0	0	22,664	0
Professional fees	199,863	182,343	384,485	197,125
Total operating expenses	316,224	553,950	784,801	748,343
Loss from operations	(309,373)	(537,581)	(751,970)	(721,101)
Other income (expense)
Interest expense	(281,478)	(269,382)	(441,437)	(380,832)
Change in fair value of derivative liabilities	130,400	(5,320,673)	469,365	(5,552,522)
Loss on conversion convertible notes	(90,824)	0	(88,609)	0
Gain on extinguishment of convertible note	534	0	54,834	0
Gain on modification of convertible note	2,647	0	2,647	0
Gain on settlement of liabilities	0	22,805		22,805
Total other expense	(238,721)	(5,567,250)	(3,200)	(5,910,549)
Loss before income taxes	(548,094)	(6,104,831)	(755,170)	(6,631,650)
Provision for income taxes	0	0	0	0
Net loss	$ (548,094)	$ (6,104,831)	$ (755,170)	$ (6,631,650)
Basic and diluted loss per Common Share	$ (0.00)	$ (0.06)	$ (0.01)	$ (0.07)
Basic and diluted weighted average number of common shares outstanding	141,322,233	94,819,184	121,511,509	94,756,839

Consolidated Statement of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (755,170)	$ (6,631,650)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation-services	0	177,401
Stock-based compensation-commitment fees	22,664	0
Restricted stock - based compensation	258,348	0
Amortization of debt discount	343,678	300,252
Depreciation	8,748	4,373
Change in fair value of derivative liabilities	(469,365)	5,552,522
Gain on extinguishment of convertible note	(54,834)	0
Gain on modification of convertible note	(2,647)	0
Gain on settlement of liability	0	22,805
Loss on conversion of convertible note	88,609	0
Prepaid expenses	25,250	(40,917)
Other receivable	(100)	0
Accounts payable and accrued liabilities	308,652	5,055
Accrued interest-related parties	12,906	12,922
Net Cash used in Operating Activities	(213,261)	(597,237)
CASH FLOWS FROM INVESTING ACTIVITIES:
Improvement leased property	0	(26,241)
Net Cash used in Investing Activities	0	(26,241)
CASH FLOWS FROM FINANCING ACTIVITIES:
Advances for convertible notes to be issued	45,000	15,000
Bank overdraft	2,505	0
Deferred offering cost	0	(55,000)
Proceeds from loans payable	0	35,000
Proceeds from convertible notes	140,300	734,559
Repayment of convertible notes	(30,000)	0
Repayment of loans payable	0	(36,000)
Proceeds from related parties	32,785	7,250
Repayment loan of related parties	(86,160)	(77,548)
Net Cash provided by Financing Activities	104,430	623,261
Net change in cash	(108,831)	(217)
Cash, beginning of period	126,807	18,374
Cash, end of period	17,976	18,157
Supplemental cash flow information
Cash paid for interest	0	0
Cash paid for taxes	0	0
Non-cash Investing and Financing transactions:
Common stock issued for compensation -management	565	0
Dividend in form of warrants	0	23,147,870
Common stock issued for compensation- services	0	177,401
Common stock issued for convertible note-commitment shares	22,664	623,877
Common stock issued for conversion convertible notes	329,182	0
Derivative liabilities recognized as debt discount	427,749	429,972
Issuance convertible note in exchange with another convertible note	63,199	0
Derivatives liabilities recognized as debt discount -warrant	0	510,000
Common stock commitment payable recognized as debt discount	16,071	0
Issuance Series C Preferred Stock in exchange with due to related party	$ 1,000	$ 0

Consolidated Balance sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current assets
Cash	$ 17,976	$ 126,807
Prepaid expenses	20,000	45,250
Other receivable	380	280
Deferred offering costs	61,600	61,600
Total current assets	99,956	233,937
Property and equipment, net	0	8,748
Total Assets	99,956	242,685
Current Liabilities
Accounts payable and accrued liabilities	1,424,122	1,172,757
Advances for convertible notes to be issued	45,000	0
Due to related party	3,275	3,275
Notes payable - related parties	766,272	807,740
Loans payable, net discount of $0	434,500	434,500
Convertible notes, net discount of $253,000 and $121,464	1,526,661	1,613,580
Derivative liabilities	973,428	1,156,230
Total Current Liabilities	5,173,258	5,188,082
Total Liabilities	5,173,258	5,188,082
Stockholders' Deficit
Preferred stock: 10,000,000 authorized; $0.001 par value 1,000,000 and 0 shares of Series C Preferred Stock issued and outstanding, respectively	1,000	0
Common stock: 3,490,000,000 authorized; $0.001 par value 174,150,989 and 99,061,523 shares issued and outstanding, respectively	174,151	99,062
Additional paid in capital	29,620,211	29,085,106
Common stock to be issued, 15,046,667 shares	86,071	70,000
Collateral stock, at par value: 2,775,000 shares	(2,775)	(2,775)
Accumulated deficit	(34,951,960)	(34,196,790)
Total Stockholders' Deficit	(5,073,302)	(4,945,397)
Total Liabilities and Stockholders' Deficit	$ 99,956	$ 242,685